Literature DB >> 16641151

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.

William McClellan1, David G Warnock, Leslie McClure, Ruth C Campbell, Britt B Newsome, Virginia Howard, Mary Cushman, George Howard.   

Abstract

The racial disparity in the incidence of ESRD exemplified by the three- to four-fold excess risk among black compared with white individuals in the United States is not reflected in the prevalence of less severe degrees of impaired kidney function among black compared with white individuals. The four-variable Modification of Diet in Renal Disease study equation was used to evaluate the black-to-white prevalence of impaired kidney function with increasing severity of impairment among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a nationally representative, population-based cohort of individuals who are 45 yr and older. An estimated GFR (eGFR)<60 ml/min per 1.73 m2 was present in 43.3% of the 20,667 REGARDS participants and was slightly less prevalent among black than white patients (33.7 versus 49.9%; prevalence odds ratio 0.51; 95% confidence interval [CI] 0.48 to 0.54). The lower prevalence among black patients was not uniform as eGFR declined. After controlling for other patient characteristics, the black-to-white odds ratio was 0.42 (95% CI 0.40 to 0.46) at an eGFR of 50 to 59 ml/min per 1.73 m2 and increased to 1.73 (95% CI 1.02 to 2.94) at an eGFR of 10 to 19 ml/min per 1.73 m2. The disparity in prevalence of impaired kidney function among white compared with black patients reversed as the severity of impaired kidney function increased. Factors that are responsible for the increasing prevalence of severely impaired kidney function among black patients remain to be determined.

Entities:  

Mesh:

Year:  2006        PMID: 16641151     DOI: 10.1681/ASN.2005111200

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  75 in total

1.  Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.

Authors:  Dana V Rizk; Orlando Gutierrez; Emily B Levitan; William M McClellan; Monika Safford; Elsayed Z Soliman; David G Warnock; Paul Muntner
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

2.  Racial differences in the incidence of chronic kidney disease.

Authors:  Paul Muntner; Britt Newsome; Holly Kramer; Carmen A Peralta; Yongin Kim; David R Jacobs; Catarina I Kiefe; Cora E Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

3.  Kidney function can improve in patients with hypertensive CKD.

Authors:  Bo Hu; Crystal Gadegbeku; Michael S Lipkowitz; Stephen Rostand; Julia Lewis; Jackson T Wright; Lawrence J Appel; Tom Greene; Jennifer Gassman; Brad C Astor
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

4.  Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors?

Authors:  Ryo Kido; Yugo Shibagaki; Kazuhiro Iwadoh; Ichiro Nakajima; Shohei Fuchinoue; Toshiro Fujita; Satoshi Teraoka
Journal:  Clin Exp Nephrol       Date:  2010-03-26       Impact factor: 2.801

5.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

6.  A critical evaluation of chronic kidney disease--should isolated reduced estimated glomerular filtration rate be considered a 'disease'?

Authors:  Emilio D Poggio; Andrew D Rule
Journal:  Nephrol Dial Transplant       Date:  2008-12-22       Impact factor: 5.992

7.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

8.  Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.

Authors:  Stephen F Derose; Mark P Rutkowski; Peter W Crooks; Jiaxiao M Shi; Jean Q Wang; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Nathan W Levin; Steven J Jacobsen
Journal:  Am J Kidney Dis       Date:  2013-03-15       Impact factor: 8.860

9.  Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS Cohort Study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; Mary Cushman; George Howard; Paul Audhya; Jerome L Abramson; David G Warnock
Journal:  Am J Nephrol       Date:  2008-07-26       Impact factor: 3.754

10.  Use of renal function measurements for assessing fracture risk in postmenopausal women.

Authors:  James T McCarthy; Andrew D Rule; Sara J Achenbach; Eric J Bergstralh; Sundeep Khosla; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.